open access

Vol 4, No 4 (1999)
Untitled
Published online: 1999-01-01
Submitted:
Get Citation

16 New approaches to follicular lymphona

A Z Rohatiner
DOI: 10.1016/S1507-1367(99)70016-7
·
Rep Pract Oncol Radiother 1999;4(4):107.

open access

Vol 4, No 4 (1999)
Untitled
Published online: 1999-01-01
Submitted:

Abstract

With conventional therapy, follicular Iymphona remains incurable for most patients. An experimental approach is therefore justified.

Recognition of the association between follicular Iymphona and the (14;18) translocation and the possibility of detecting residual disease at the molecular level using the polymerase chain reaction (PCR), have led to the concept of ‘molecular remission’.

Several new approaches, some of which have been reported to result in ‘molecular remission’ eg. the chimaeric antibody antti-CD20 and the combination Fludarabine, Mitoxantrone and Dexamethasone are currently being evaluated at SBH. These and other treatment options, including high dose treatment (Cyclophosphamide + total body irradiation) supported by autologous haemopoietic progenitor cells, radio-labelled anti-CD20 and the nonmyeloablative regimen comprising Fladarabine and Cyclophosphamide supported by allogeneic bone marrow transplantation will be discussed.

Abstract

With conventional therapy, follicular Iymphona remains incurable for most patients. An experimental approach is therefore justified.

Recognition of the association between follicular Iymphona and the (14;18) translocation and the possibility of detecting residual disease at the molecular level using the polymerase chain reaction (PCR), have led to the concept of ‘molecular remission’.

Several new approaches, some of which have been reported to result in ‘molecular remission’ eg. the chimaeric antibody antti-CD20 and the combination Fludarabine, Mitoxantrone and Dexamethasone are currently being evaluated at SBH. These and other treatment options, including high dose treatment (Cyclophosphamide + total body irradiation) supported by autologous haemopoietic progenitor cells, radio-labelled anti-CD20 and the nonmyeloablative regimen comprising Fladarabine and Cyclophosphamide supported by allogeneic bone marrow transplantation will be discussed.

Get Citation
About this article
Title

16 New approaches to follicular lymphona

Journal

Reports of Practical Oncology and Radiotherapy

Issue

Vol 4, No 4 (1999)

Pages

107

Published online

1999-01-01

DOI

10.1016/S1507-1367(99)70016-7

Bibliographic record

Rep Pract Oncol Radiother 1999;4(4):107.

Authors

A Z Rohatiner

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk, Poland
tel.:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: journals@viamedica.pl